title: [Is there a risk of revision in connection with the drug reform?].
authors.forename: Sigvard
authors.initials: S
authors.lastname: Danielsson
mesh_terms: D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics; D018166:Health Care Reform; D006801:Humans; D013548:Sweden